FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Data Not Conclusive on Amylyx ALS Drug: FDA

FDA reviewers dismiss new analyses and data from Amylyx that were intended to provide confirmatory evidence to support approval of its amyotrophic lat...

latest-news-card-1
Human Drugs

FDA Observations from 3 Biocon Biologics Inspections

FDA issues a form FDA-483 with multiple inspection observations to Indias Biocon Biologics following three inspections at manufacturing sites in India...

latest-news-card-1
Medical Devices

Cue Health Seeks De Novo for At-Home Flu Test

Cue Health files a de novo marketing submission for its Cue Flu Molecular Test for at-home and point-of-care use.

latest-news-card-1
Human Drugs

GDUFA Research Supports Generic Drug Development

The FDA FY 2021 GDUFA Science and Research Outcomes Report demonstrates how GDUFA research projects have contributed to the development of generic dru...

latest-news-card-1
Human Drugs

FDA, C-Path Exploring Lysosomal Diseases Group

FDA says it is partnering with the Critical Path Institute to explore creating a Lysosomal Diseases Consortium as part of the Accelerating Rare Diseas...

latest-news-card-1
Medical Devices

eCential Robotics Bone Surgical System Cleared

FDA clears an eCential Robotics 510(k) for its 3D imaging, navigation and robotics guidance system for use in bone surgical procedures.

latest-news-card-1
Medical Devices

Respironics Troubles Broaden as it Pays $24 Mil. Over False Claims

As it negotiates a consent decree over its ventilators and other airway devices with the Department of Justice (DoJ), the company agrees to settle Fal...

latest-news-card-1
Medical Devices

Integra CereLink Monitor Recall is Class 1

FDA says the Integra recall of 388 CereLink intracranial pressure monitors is Class 1.

latest-news-card-1
Federal Register

Oncologic Drugs Panel to Review Y-mAbs BLA

Federal Register notice: FDA announces a 10/28 Oncologic Drugs Advisory Committee meeting.

latest-news-card-1
Federal Register

Panel to Vote on SolvD Genetic Test

Federal Register notice: FDA announces a 10/20 advisory committee meeting that will vote on a SolvD test to identify opioid use disorder at-risk patie...